Pain relief with percutaneous trochanteroplasty in a patient with bilateral trochanteric myelomatous lytic lesions

Sayed E. Wahezi, Kyle Silva, Shervin Najafi

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Multiple myeloma is a hematologic malignancy associated with destructive bone loss. Lytic lesions, a hallmark of this cancer, can result in significant morbidity because of associated pain and structural osseous compromise. Osteoplasty has demonstrated efficacy in the treatment of myelomatous pain within the axial skeleton; however, there is limited evidence supporting the utility of osteoplasty to treat extra-spinal lesions. We describe a 67 year-old woman with stable IgA lambda multiple myeloma with sentinel bilateral greater trochanteric lytic lesions that was referred to our interventional pain management clinic for evaluation of bilateral lateral hip pain. Conservative treatment options including physical therapy, non-steroidal anti-inflammatory drugs (NSAIDs), oral opiates, and local corticosteroid injections to bilateral trochanteric bursae failed to offer pain relief. The patient underwent minimally invasive percutaneous trochanteroplasty with concomitant core biopsy of her bilateral trochanteric lytic lesions. The intended goals of this novel procedure were to determine the cause of the suspected lytic lesions, provide pain relief, and offer structural stability by safely implanting bone cement as part of a fracture prevention strategy. At 12 month followup, the patient’s pain improved by 70% and she no longer required the use of pain medication. The patient also displayed a significant improvement in her day-to-day functioning and quality of life.

Original languageEnglish (US)
Pages (from-to)E57-E63
JournalPain Physician
Volume18
Issue number1
StatePublished - 2015

Fingerprint

Pain
Multiple Myeloma
Opiate Alkaloids
Pain Clinics
Bone Cements
Hematologic Neoplasms
Pain Management
Skeleton
Immunoglobulin A
Hip
Adrenal Cortex Hormones
Anti-Inflammatory Agents
Quality of Life
Morbidity
Biopsy
Bone and Bones
Injections
Pharmaceutical Preparations
Neoplasms
Therapeutics

Keywords

  • Greater trochanter
  • Multiple myeloma
  • Osteoplasty
  • Pain
  • Percutaneous
  • Trochanteroplasty

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

Pain relief with percutaneous trochanteroplasty in a patient with bilateral trochanteric myelomatous lytic lesions. / Wahezi, Sayed E.; Silva, Kyle; Najafi, Shervin.

In: Pain Physician, Vol. 18, No. 1, 2015, p. E57-E63.

Research output: Contribution to journalArticle

@article{82403576f358441bb8ceb5d095b0ce31,
title = "Pain relief with percutaneous trochanteroplasty in a patient with bilateral trochanteric myelomatous lytic lesions",
abstract = "Multiple myeloma is a hematologic malignancy associated with destructive bone loss. Lytic lesions, a hallmark of this cancer, can result in significant morbidity because of associated pain and structural osseous compromise. Osteoplasty has demonstrated efficacy in the treatment of myelomatous pain within the axial skeleton; however, there is limited evidence supporting the utility of osteoplasty to treat extra-spinal lesions. We describe a 67 year-old woman with stable IgA lambda multiple myeloma with sentinel bilateral greater trochanteric lytic lesions that was referred to our interventional pain management clinic for evaluation of bilateral lateral hip pain. Conservative treatment options including physical therapy, non-steroidal anti-inflammatory drugs (NSAIDs), oral opiates, and local corticosteroid injections to bilateral trochanteric bursae failed to offer pain relief. The patient underwent minimally invasive percutaneous trochanteroplasty with concomitant core biopsy of her bilateral trochanteric lytic lesions. The intended goals of this novel procedure were to determine the cause of the suspected lytic lesions, provide pain relief, and offer structural stability by safely implanting bone cement as part of a fracture prevention strategy. At 12 month followup, the patient’s pain improved by 70{\%} and she no longer required the use of pain medication. The patient also displayed a significant improvement in her day-to-day functioning and quality of life.",
keywords = "Greater trochanter, Multiple myeloma, Osteoplasty, Pain, Percutaneous, Trochanteroplasty",
author = "Wahezi, {Sayed E.} and Kyle Silva and Shervin Najafi",
year = "2015",
language = "English (US)",
volume = "18",
pages = "E57--E63",
journal = "Pain Physician",
issn = "1533-3159",
publisher = "Association of Pain Management Anesthesiologists",
number = "1",

}

TY - JOUR

T1 - Pain relief with percutaneous trochanteroplasty in a patient with bilateral trochanteric myelomatous lytic lesions

AU - Wahezi, Sayed E.

AU - Silva, Kyle

AU - Najafi, Shervin

PY - 2015

Y1 - 2015

N2 - Multiple myeloma is a hematologic malignancy associated with destructive bone loss. Lytic lesions, a hallmark of this cancer, can result in significant morbidity because of associated pain and structural osseous compromise. Osteoplasty has demonstrated efficacy in the treatment of myelomatous pain within the axial skeleton; however, there is limited evidence supporting the utility of osteoplasty to treat extra-spinal lesions. We describe a 67 year-old woman with stable IgA lambda multiple myeloma with sentinel bilateral greater trochanteric lytic lesions that was referred to our interventional pain management clinic for evaluation of bilateral lateral hip pain. Conservative treatment options including physical therapy, non-steroidal anti-inflammatory drugs (NSAIDs), oral opiates, and local corticosteroid injections to bilateral trochanteric bursae failed to offer pain relief. The patient underwent minimally invasive percutaneous trochanteroplasty with concomitant core biopsy of her bilateral trochanteric lytic lesions. The intended goals of this novel procedure were to determine the cause of the suspected lytic lesions, provide pain relief, and offer structural stability by safely implanting bone cement as part of a fracture prevention strategy. At 12 month followup, the patient’s pain improved by 70% and she no longer required the use of pain medication. The patient also displayed a significant improvement in her day-to-day functioning and quality of life.

AB - Multiple myeloma is a hematologic malignancy associated with destructive bone loss. Lytic lesions, a hallmark of this cancer, can result in significant morbidity because of associated pain and structural osseous compromise. Osteoplasty has demonstrated efficacy in the treatment of myelomatous pain within the axial skeleton; however, there is limited evidence supporting the utility of osteoplasty to treat extra-spinal lesions. We describe a 67 year-old woman with stable IgA lambda multiple myeloma with sentinel bilateral greater trochanteric lytic lesions that was referred to our interventional pain management clinic for evaluation of bilateral lateral hip pain. Conservative treatment options including physical therapy, non-steroidal anti-inflammatory drugs (NSAIDs), oral opiates, and local corticosteroid injections to bilateral trochanteric bursae failed to offer pain relief. The patient underwent minimally invasive percutaneous trochanteroplasty with concomitant core biopsy of her bilateral trochanteric lytic lesions. The intended goals of this novel procedure were to determine the cause of the suspected lytic lesions, provide pain relief, and offer structural stability by safely implanting bone cement as part of a fracture prevention strategy. At 12 month followup, the patient’s pain improved by 70% and she no longer required the use of pain medication. The patient also displayed a significant improvement in her day-to-day functioning and quality of life.

KW - Greater trochanter

KW - Multiple myeloma

KW - Osteoplasty

KW - Pain

KW - Percutaneous

KW - Trochanteroplasty

UR - http://www.scopus.com/inward/record.url?scp=84923039180&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84923039180&partnerID=8YFLogxK

M3 - Article

C2 - 25675071

AN - SCOPUS:84923039180

VL - 18

SP - E57-E63

JO - Pain Physician

JF - Pain Physician

SN - 1533-3159

IS - 1

ER -